Suppr超能文献

高危急性髓系白血病患者的代码状态转变。

Code status transitions in patients with high-risk acute myeloid leukemia.

机构信息

Department of Medicine, and.

Massachusetts General Cancer Center, Massachusetts General Hospital, Boston MA.

出版信息

Blood Adv. 2022 Jul 26;6(14):4208-4215. doi: 10.1182/bloodadvances.2022007009.

Abstract

Patients with high-risk acute myeloid leukemia (AML) often experience intensive medical care at the end of life (EOL), including high rates of hospitalizations and intensive care unit (ICU) admissions. Despite this, studies examining code status transitions are lacking. We conducted a mixed-methods study of 200 patients with high-risk AML enrolled in supportive care studies at Massachusetts General Hospital between 2014 and 2021. We defined high-risk AML as relapsed/refractory or diagnosis at age ≥60. We used a consensus-driven medical record review to characterize code status transitions. At diagnosis, 86.0% (172/200) of patients were "full code" (38.5% presumed, 47.5% confirmed) and 8.5% had restrictions on life-sustaining therapies. Overall, 57.0% of patients experienced a transition during the study period. The median time from the last transition to death was 2 days (range, 0-350). Most final transitions (71.1%) were to comfort measures near EOL; only 60.5% of patients participated in these last transitions. We identified 3 conversation types leading to transitions: informative conversations focusing on futility after clinical deterioration (51.0%), anticipatory conversations at the time of acute deterioration (32.2%), and preemptive conversations (15.6%) before deterioration. Younger age (B = 0.04; P = .002) and informative conversations (B = -2.79; P < .001) were associated with shorter time from last transition to death. Over two-thirds of patients were "presumed full code" at diagnosis of high-risk AML, and most experienced code status transitions focused on the futility of continuing life-sustaining therapies near EOL. These results suggest that goals-of-care discussions occur late in the illness course for patients with AML and warrant interventions to increase earlier discussions regarding EOL preferences.

摘要

高危急性髓系白血病(AML)患者在生命末期(EOL)通常需要接受强化医疗护理,包括高频率的住院和重症监护病房(ICU)入院。尽管如此,目前缺乏研究来探讨患者的医嘱状态转变。我们对 200 名于 2014 年至 2021 年期间在马萨诸塞州综合医院参加支持性护理研究的高危 AML 患者进行了一项混合方法研究。我们将高危 AML 定义为复发/难治或年龄≥60 岁时诊断。我们使用基于共识的病历回顾来描述医嘱状态的转变。在诊断时,86.0%(172/200)的患者为“全面医嘱”(38.5%为假设医嘱,47.5%为确认医嘱),8.5%的患者对维持生命的治疗存在限制。总体而言,57.0%的患者在研究期间经历了医嘱状态的转变。从最后一次医嘱状态转变到死亡的中位时间为 2 天(范围为 0-350 天)。大多数最后一次医嘱状态的转变(71.1%)是为了在 EOL 时提供舒适护理,只有 60.5%的患者参与了这些最后一次医嘱状态的转变。我们确定了导致医嘱状态转变的 3 种对话类型:在临床恶化后关注治疗无效的告知性对话(51.0%)、在急性恶化时进行的预期性对话(32.2%)和在恶化前进行的预防性对话(15.6%)。年龄较轻(B=0.04;P=0.002)和告知性对话(B=-2.79;P<0.001)与从最后一次医嘱状态转变到死亡的时间较短相关。超过三分之二的高危 AML 患者在诊断时被假定为“全面医嘱”,并且大多数医嘱状态的转变都集中在 EOL 时继续维持生命治疗的无效性上。这些结果表明,AML 患者的治疗目标讨论发生在疾病晚期,需要干预措施来增加关于 EOL 偏好的早期讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/9327548/bf87fbded1cc/advancesADV2022007009absf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验